Phakic IOL counters LASIK slowdown

November 1, 2008

STAAR Surgical's Visian implantable collamer lens (ICL) & toric ICL (TICL) will allow surgeons to differentiate themselves in the slowing LASIK marketplace, according to the firm's president of international operations, David Bailey.

STAAR Surgical’s Visian implantable collamer lens (ICL) & toric ICL (TICL) will allow surgeons to differentiate themselves in the slowing LASIK marketplace, according to the firm’s president of international operations, David Bailey.

Mark Rosenberg, CEO of the Barnet Dulaney Perkins eye centre in Phoenix, Arizona, US, agrees and has seen strong growth in the lens-based sector. But, before this can be achieved, he says practices need to work to overcome the barriers to ICL uptake amongst patients. He says clinics must present ICLs at the beginning of the consultation process, rather than only where LASIK is not an option. Rosenberg says doctors need to shift the way they think, embracing the broader concept of vision correction rather than only LASIK.

“The only question for surgeons is, are you going to be left off the train and wind up giving up on refractive surgery, or are you going to move on?”

 

To read OTE's full news coverage of the XXVI congress of the European Society of Cataract & Refractive Surgery, please click here.